SymBio Pharmaceuticals Limited
Develops and commercializes drugs for oncology, hematology, and rare diseases.
4582 | T
Overview
Corporate Details
- ISIN(s):
- JP3383050006
- LEI:
- Country:
- Japan
- Address:
- 港区虎ノ門四丁目１番２８号
- Website:
- https://www.symbiopharma.com/en/
- Sector:
- Manufacturing
Description
SymBio Pharmaceuticals Limited is a specialty pharmaceutical company focused on the development and commercialization of new drug candidates. The company's business model involves acquiring development and marketing rights for promising pharmaceuticals from other bio-ventures and pharmaceutical firms to address unmet medical needs. Its core therapeutic areas include oncology, hematology, and rare diseases. A key product in its portfolio is bendamustine hydrochloride (Treakisym), an agent used in the treatment of hematologic cancers such as low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. SymBio aims to deliver innovative treatments to patients by advancing its pipeline of specialized drugs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2016-03-31 09:31 |
有価証券報告書－第11期(2015/01/01－2015/12/31)
|
Japanese | ZIP • 1.1 MB | ||
| 2015-11-09 08:55 |
四半期報告書－第11期第3四半期(2015/07/01－2015/09/30)
|
Japanese | ZIP • 147.5 KB |
Automate Your Workflow. Get a real-time feed of all SymBio Pharmaceuticals Limited filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SymBio Pharmaceuticals Limited
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SymBio Pharmaceuticals Limited via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
